14M

{(3S)-1-[5-(cyclohexylcarbamoyl)-6-(propylsulfanyl)pyridin-2-yl]piperidin-3-yl}acetic acid


Toggle HydrogenToggle Labels

Chemical Component Summary

Name{(3S)-1-[5-(cyclohexylcarbamoyl)-6-(propylsulfanyl)pyridin-2-yl]piperidin-3-yl}acetic acid
Identifiers2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanyl-pyridin-2-yl]piperidin-3-yl]ethanoic acid
FormulaC22 H33 N3 O3 S
Molecular Weight419.581
TypeNON-POLYMER
Isomeric SMILESCCCSc1c(ccc(n1)N2CCC[C@H](C2)CC(=O)O)C(=O)NC3CCCCC3
InChIInChI=1S/C22H33N3O3S/c1-2-13-29-22-18(21(28)23-17-8-4-3-5-9-17)10-11-19(24-22)25-12-6-7-16(15-25)14-20(26)27/h10-11,16-17H,2-9,12-15H2,1H3,(H,23,28)(H,26,27)/t16-/m0/s1
InChIKeyNCDZABJPWMBMIQ-INIZCTEOSA-N

Chemical Details

Formal Charge0
Atom Count62
Chiral Atom Count1
Bond Count64
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB14875 
NameAZD-4017
Groups investigational
DescriptionAZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).
SynonymsAZD-4017
Categories
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1, antagonists & inhibitors
  • Nicotinic Acids
  • Pyridines
CAS number1024033-43-9

Related Resource References

Resource NameReference
Pharos CHEMBL2153191
PubChem 24946280
ChEMBL CHEMBL2153191